secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempus AI, Inc. (TEM)
CIK:        0001717115
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0000950170-24-120663
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempus AI Q3 revenue $180.9M (+33% YoY), net loss $75.8M, agrees to buy Ambry Genetics for $600M
--------------------------------------------------------------------------------

- Q3 revenue $180.9M (+33% YoY); net loss $75.8M (incl. $22.2M stock comp); Adj EBITDA -$21.8M (improved $14.4M YoY).
- FY2024 guidance: revenue ~$700M (~32% growth), Adj EBITDA ~($105M), improvement of ~$50M over 2023.
- Acquired Ambry Genetics for $600M ($375M cash + $225M shares); Ambry expects >$300M rev, >$40M EBITDA in CY2024.
- Data & services rev +64.4% YoY, Insights rev +86.6%; Genomics unit growth 23.9%, rev +20.3%.
- Debt financing: $300M increase from Ares; cash & marketable securities $466.3M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1717115/000095017024120663/0000950170-24-120663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1717115/000095017024120663/tem-20241104.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-120663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer